MYND — MYND Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$1.22m
- CA$4.22m
- 16
- 17
- 40
- 14
Annual cashflow statement for MYND Life Sciences, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.056 | -4.37 | -3.57 | -1.52 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 0 | 1.68 | 0.599 | -0.451 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.054 | -0.213 | 1.22 | 1.75 |
| Change in Accounts Receivable | ||||
| Change in Other Assets | ||||
| Change in Payable / Accrued Expenses | ||||
| Cash from Operating Activities | -0.003 | -2.98 | -1.82 | -0.198 |
| Capital Expenditures | — | -0.044 | — | — |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0 | 2.17 | -0.08 | 0.198 |
| Sale of Business | ||||
| Sale of Fixed Assets | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0 | 2.13 | -0.08 | 0.198 |
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 0.003 | 2.75 | 0 | — |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0 | 1.9 | -1.9 | -0 |